Lost password ?
Mouwasat Medical
Softer-than-expected revenue growth in Q1
- "We have reduced our top-line growth from 7% to 6% after the company missed our estimates in Q1 2025. The reported net profit was revised upward from SAR685m to SAR719m, but the adjusted net profit ..."
Executive summary
Conflicts of Interest
Pages 39
Language English
Publish on May 9, 2025
€ 500
VAT Exl.
You may also be interested by these reports :
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.